This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

2011 Consumer Recall Alerts

CooperVision recalled hundreds of thousands of Avaira Toric contact lenses, according to Oct. 13 reports, the eye care company's second recall announcement in two months.

The latest recall involved 600,000 contact lenses that entered the U.S. market, though more than 8 million were said to have been affected by the problem.

The recall was instituted because wearers complained of pain, red eyes, and blurry vision. MSNBC reported that some people wearing the Avaira Toric contact lenses necessitated visits to the emergency room because they were in such excruciating pain.

Wearers' symptoms were caused by a residue on the lenses, which resulted from a manufacturing problem.

CooperVision said it "has fully cooperated with the FDA and continues to closely monitor the situation." It notified customers, and told eye care practitioners to inform their patients about the recall.

3 of 139

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AMZN $445.10 14.13%
GM $35.59 -0.92%
JNJ $101.08 0.62%
KR $71.70 1.09%
SNE $31.34 2.02%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs